Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD
Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to gather information on the combination Zetia® (Ezetimibe)
and Urso Forte® with respect to sterol balance and their effects on biomarkers of liver
function in subjects with nonalcoholic fatty liver disease (NAFLD).